Andrew Pierce, senior executive at French biotech Owkin, on how artificial intelligence can make the drug development process ...
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
SELLAS Life Sciences CEO Angelos Stergiou and "Some Future Day" author Marc Beckman predict artificial intelligence will ...
Artificial Intelligence (AI) was a buzzword around Wall Street for most of 2024. AI has shown immense promise but comes with ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
24/7 Wall St. on MSN7d
I Was Convinced Biotech Stocks Were Too Risky—This Innovation’s Changing the GameThe biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it’s really tough ...
AI, biotech and affordable clean energy will be the focus of an EU drive to make the bloc globally competitive and ensure it ...
Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...
Debut, the biotech beauty leader, announced today the launch of BeautyORB™, an AI-powered innovation engine that provides a ...
The Warren-headquartered clinical-stage specialty immunotherapy biotechnology company focuses on the development of T-cell ...
EU to Target AI, Biotech, Cheap Energy in Global Competitiveness Push By Philip Blenkinsop, Kate Abnett and Michel Rose BRUSSELS/PARIS (Reuters) -AI, biotech and affordable clean energy will be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback